Jones D - Search Results

1

BTK^C481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.

Woyach JA, Ruppert AS, Guinn D, Lehman A, Blachly JS, Lozanski A, Heerema NA, Zhao W, Coleman J, Jones D, Abruzzo L, Gordon A, Mantel R, Smith LL, McWhorter S, Davis M, Doong TJ, Ny F, Lucas M, Chase W, Jones JA, Flynn JM, Maddocks K, Rogers K, Jaglowski S, Andritsos LA, Awan FT, Blum KA, Grever MR, Lozanski G, Johnson AJ, Byrd JC. Woyach JA, et al. Among authors: jones d, jones ja. J Clin Oncol. 2017 May 1;35(13):1437-1443. doi: 10.1200/JCO.2016.70.2282. Epub 2017 Feb 13. J Clin Oncol. 2017. PMID: 28418267 Free PMC article. Clinical Trial.

2

Chronic myeloproliferative diseases with the t(5;12)(q33;p13): clonal evolution is associated with blast crisis.

Han X, Medeiros LJ, Abruzzo LV, Jones D, Lin P. Han X, et al. Among authors: jones d. Am J Clin Pathol. 2006 Jan;125(1):49-56. Am J Clin Pathol. 2006. PMID: 16482991

3

Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia.

Sargent R, Jones D, Abruzzo LV, Yao H, Bonderover J, Cisneros M, Wierda WG, Keating MJ, Luthra R. Sargent R, et al. Among authors: jones d. J Mol Diagn. 2009 Jan;11(1):25-34. doi: 10.2353/jmoldx.2009.080037. Epub 2008 Dec 12. J Mol Diagn. 2009. PMID: 19074592 Free PMC article.

4

Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance.

Zhang WW, Cortes JE, Yao H, Zhang L, Reddy NG, Jabbour E, Kantarjian HM, Jones D. Zhang WW, et al. Among authors: jones d. J Clin Oncol. 2009 Aug 1;27(22):3642-9. doi: 10.1200/JCO.2008.19.4076. Epub 2009 Jun 8. J Clin Oncol. 2009. PMID: 19506164 Free PMC article.

5

Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemia.

Cortes JE, Jones D, O'Brien S, Jabbour E, Ravandi F, Koller C, Borthakur G, Walker B, Zhao W, Shan J, Kantarjian H. Cortes JE, et al. Among authors: jones d. J Clin Oncol. 2010 Jan 20;28(3):398-404. doi: 10.1200/JCO.2009.25.4920. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008620 Free PMC article. Clinical Trial.

6

Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phase.

Cortes JE, Jones D, O'Brien S, Jabbour E, Konopleva M, Ferrajoli A, Kadia T, Borthakur G, Stigliano D, Shan J, Kantarjian H. Cortes JE, et al. Among authors: jones d. J Clin Oncol. 2010 Jan 20;28(3):392-7. doi: 10.1200/JCO.2009.25.4896. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008621 Free PMC article.

7

A pathway-based gene signature correlates with therapeutic response in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Zuo Z, Jones D, Yao H, Thomas DA, O'Brien S, Ravandi F, Kantarjian HM, Abruzzo LV, Medeiros LJ, Chen SS, Luthra R. Zuo Z, et al. Among authors: jones d. Mod Pathol. 2010 Nov;23(11):1524-34. doi: 10.1038/modpathol.2010.137. Epub 2010 Aug 20. Mod Pathol. 2010. PMID: 20729815 Free article.

8

PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment.

Jones D, Woyach JA, Zhao W, Caruthers S, Tu H, Coleman J, Byrd JC, Johnson AJ, Lozanski G. Jones D, et al. Leukemia. 2017 Jul;31(7):1645-1647. doi: 10.1038/leu.2017.110. Epub 2017 Apr 3. Leukemia. 2017. PMID: 28366935 No abstract available.

9

Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival.

Cosgrove CM, Cohn DE, Hampel H, Frankel WL, Jones D, McElroy JP, Suarez AA, Zhao W, Chen W, Salani R, Copeland LJ, O'Malley DM, Fowler JM, Yilmaz A, Chassen AS, Pearlman R, Goodfellow PJ, Backes FJ. Cosgrove CM, et al. Among authors: jones d. Gynecol Oncol. 2017 Sep;146(3):588-595. doi: 10.1016/j.ygyno.2017.07.003. Epub 2017 Jul 11. Gynecol Oncol. 2017. PMID: 28709704 Free PMC article.

10

Potent induction of apoptosis by givinostat in BCR-ABL1-positive and BCR-ABL1-negative precursor B-cell acute lymphoblastic leukemia cell lines.

Yao C, Zhang G, Walker A, Zhao KY, Li Y, Lyu L, Tang Y, Ru P, Jones D, Zhao W. Yao C, et al. Among authors: jones d. Leuk Res. 2017 Sep;60:129-134. doi: 10.1016/j.leukres.2017.08.003. Epub 2017 Aug 9. Leuk Res. 2017. PMID: 28818808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,040 results

Search Page